TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release financial results for the fourth quarter 2025 ended December 31, 2025, after market close on March 12, 2026. The Company will subsequently hold a conference call on March 13, 2026, at 9:00am EST, hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.
To register for the conference call please visit:
https://us06web.zoom.us/webinar/register/WN_eSqnynaoQ9Kbb2N-fzvJOA#/registration
About VitalHub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 500 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please visit www.vitalhub.com and LinkedIn.
Contact Information
Christian Sgro, CPA, CA, CFA
Head of IR and M&A Specialist
(365) 363-6433
christian.sgro@vitalhub.com
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@vitalhub.com


Đề xuất
From Product Exports to Global Standards: Feng Xingya Outlines the Next Stage of China’s Auto Globalization
GAC Chairman Highlights “Standards Going Global” to Drive High-Quality Overseas Expansion
Global Times: Understanding ‘people’ at the heart of Healthy China
MIFF 2026 AWARDS HONOUR DESIGN EXCELLENCE IN THE FURNITURE INDUSTRY
Bybit Announces Departure of Co-CEO Helen Liu as She Embarks on Entrepreneurial Journey
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions